Primaxa ODT — A New Formulation

UI/UX Design
Client

PRIMAXA ODT

OVERVIEW
J2Bio-Pharma, LLC, is launching PRIMAXA ODT, the first and only orally disintegrating tablet (ODT) formulation of primidone. It is designed to treat epileptic seizures in pediatric and adult patients aged 1 and older , offering a vital new option for those who struggle with seizure control on other medications.
No items found.
The Challenge

The launch required a comprehensive, dual-audience web presence. The challenge was balancing highly technical clinical data for Healthcare Professionals (HCPs) with accessible, empathetic guidance for patients and caregivers. The digital experience needed to effectively address common barriers to medication adherence, such as swallowing difficulties (dysphagia) and taste aversion.

View live site

The Solution

To address these distinct needs, I developed a dual-site strategy featuring a dedicated HCP portal and a complementary Caregiver site. The HCP site focused on clinical efficacy and precise dosing, highlighting data visualization like bioavailability charts. The Caregiver site utilized a supportive, educational tone, emphasizing practical benefits like the kid-friendly bubble gum flavor and the convenience of a tablet that melts on the tongue without water.

The Results

The tailored dual-site launch successfully positioned PRIMAXA ODT for its market debut. The user experience provided HCPs with the rigorous clinical data needed to confidently prescribe the new formulation , while equipping caregivers with the practical tools to manage daily treatment. Integrated request forms and clear pathways to financial assistance, such as $0 or $15 co-pay programs, further streamlined patient access to this critical treatment.